Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
You are right,he is trying to claim hearsay is fact.
The author did not have the balls to put his name to the article,nor his qualifications to talk about ED.
Futura has received it's CE mark so can now start selling.
That clearly irks the **** out of you
So you simply post reposted articles written by an anonymous author not a named ED expert.
Anyone counted how many times he has reposted that?
How much are you being paid to troll the boards?
I think the FCA need to be aware of what your are doing?
I have sent details of what you are doing I hope others do the same
market.abuse@fca.org.uk
Correct they were talking about proof of concept not what was in it.
Like a ****roach he squirms and twists every sentence.
You are so right,if they weren't talking about it we should be worried.
The fact that they are means they are worried.
Interesting to note your condescending posts.
It is quite clear you know little about erectile dysfunction.
Getting an erection is only the first issue,the second issue is being able to maintain an erection.
You quote numerous out of date and inaccurate interpretations of articles.
The phase 3 was not a failure,far from it.What was remarkable was that the Dermasy's delivery systems was as good as with a drugs and even better was comparable to first line topical treatments,with a faster onset of action and very few side effects
Let's just repeat what the Viagra website actually says.
"You will not get an erection just by taking VIAGRA."
From the Viagra website
"Get into the mood. You will not get an erection just by taking VIAGRA. You must be sexually stimulated for it to work."
He was happy to comment of the phase 3 study which is the most relevant
"The efficacy of MED3000 is remarkable and approaches the efficacy of current first line therapy but with significantly lower adverse events. With topical application, it will be of particular appeal to patients who want a fast onset of action. Lack of drug interactions with prescription products will enable the product to be used with other medications such as nitrates and other cardiovascular drugs. It can also be used in conjunction with other ED products to improve overall efficacy to patients. As such MED3000 will be of great interest to the medical community.”
Professor David Ralph
Consultant Urologist at University College London and past president of the European Society of Sexual Medicine
Its is going on sale and will fly off the shelves.
"Unique"
The efficacy of MED3000 is remarkable and approaches the efficacy of current first line therapy but with significantly lower adverse events. With topical application, it will be of particular appeal to patients who want a fast onset of action. Lack of drug interactions with prescription products will enable the product to be used with other medications such as nitrates and other cardiovascular drugs. It can also be used in conjunction with other ED products to improve overall efficacy to patients. As such MED3000 will be of great interest to the medical community.”
Professor David Ralph
Consultant Urologist at University College London and past president of the European Society of Sexual Medicine
So Liam Booth is saying these guys don't have a clue,even though ED is their daily work.
I mean come on dear.
So Liam booth is telling us the the world's leading erectile dysfunction experts can't tell the difference between KY jelly and Med3000
Really? How much more pathetic can you get.
14th April 2021
"Manufacturing scale up and commercial discussions continue to progress well "
That tells me it is being manufactured as I write and they are in the final stages of signing commecial deals.
Yes in fact they was someone who was talking about £4 plus if they get it right.
The fact remains Futura is the first co is the world to get approval for a clinically proven OTC medical device for ED.
Will sell like crazy across the planet.
Yes indeed
"The market opportunity for a clinically
proven OTC ED treatment is significant, although we consciously employ
conservative assumptions in our model, with sales of $225m in Europe and
$250m in the US. Our view is that, whilst not without risks, Futura Medical’s
share price does not reflect the likely prospects."
When one considers Viagra blasted a Billion dollars in sales in year one as a prescription only drug,the fact that Med3000 will be available over the counter immediately,I think those numbers will be smashed.
He is so desperate its pathetic.
Somebody should tell him markets look ahead.
Yes these guys look at c$cks all day long and I will trust their judgement anytime over unqualified naysayers.
Trinity went on to state
"The market opportunity for a clinically
proven OTC ED treatment is significant, although we consciously employ
conservative assumptions in our model, with sales of $225m in Europe and
$250m in the US. Our view is that, whilst not without risks, Futura Medical’s
share price does not reflect the likely prospects."
Well the largest risk for EU has now passed with the arrival of the CE mark
Trinity also stated this
"Futura Medical reported FY20 results that highlight achievement of several key
milestones, the most notable being MED3000’s regulatory approval in Europe,
with CE Marking expected by end-May. This single outcome materially de-risks
the investment case, removing a major uncertainty and paving the way for
commercialisation discussions for a number of geographies to proceed at pace."